Bumper Offer - Urjas oil Just @ Rs. 1
Telekast 5 Chewable Tablet, a prescription drug, is manufactured in various forms such as Tablet. Asthma, Allergic Rhinitis are some of its major therapeutic uses. Secondary and off-label uses of Telekast 5 Chewable Tablet have also been mentioned below.
The correct dosage of Telekast 5 Chewable Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Telekast 5 Chewable Tablet as well, which are listed below. These side effects of Telekast 5 Chewable Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Telekast 5 Chewable Tablet's effect during pregnancy is Moderate and Moderate while nursing. Warnings related to Telekast 5 Chewable Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Telekast 5 Chewable Tablet have been discussed in the sections ahead.
Drug interactions for Telekast 5 Chewable Tablet have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Telekast 5 Chewable Tablet is safe while driving, and is addiction.
Telekast 5 Chewable Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Telekast 5 Chewable Tablet safe for pregnant women?
Telekast can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Telekast right away. Take your doctor's advice before taking it again.
Is the use of Telekast 5 Chewable Tablet safe during breastfeeding?
Telekast can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Telekast 5 Chewable Tablet on the Kidneys?
Telekast may have mild side effects on the kidneys.
What is the effect of Telekast 5 Chewable Tablet on the Liver?
There may be an adverse effect on the liver after taking Telekast. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Telekast 5 Chewable Tablet on the Heart?
Very few cases of side effects of Telekast on the heart have been reported.
Telekast 5 Chewable Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Telekast 5 Chewable Tablet unless your doctor advises you to do so -
Is this Telekast 5 Chewable Tablet habit forming or addictive?
Telekast 5 Chewable Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Telekast 5 Chewable Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but consume Telekast 5 Chewable Tablet only on doctor's advice.
Is it able to treat mental disorders?
Telekast 5 Chewable Tablet is unable to treat or cure mental disorders.
Interaction between Food and Telekast 5 Chewable Tablet
There isn't any research available on the side effects of taking Telekast 5 Chewable Tablet with food.
Interaction between Alcohol and Telekast 5 Chewable Tablet
Consuming Telekast 5 Chewable Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)